RAG1 and neoplasm: To visualize the dynamic biodistribution and long-term performance of vaccine-boosted transferred T cells during the anti-tumor process, we used B16-OVA bearing Rag1−/− mice injected with OT-1 cells co-expressing luciferase, followed by immunization with the intranasal circRNA vaccine (Fig. 7a).